Pdmr Dealing: PURCHASE OF SHARES

Puretech Health

24/09/2025 07:00

RNS Number : 5270A

PureTech Health PLC

24 September 2025

 

PDMR DEALING NOTIFICATION

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Robert Lyne
Sharon Barber-Lui
John LaMattina
Michele Holcomb
2
Reason for the notification
a)
Position/status
Robert Lyne - Interim Chief Executive Officer
Sharon Barber-Lui - Interim Board Chair; Non-Executive Director
John LaMattina - Non-Executive Director
Michele Holcomb - Non-Executive Director
b)
Initial notification/Amendment
Initialnotification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
PureTech Health plc
b)
LEI
213800LVPDNO2Z9T9I39
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of PureTech Health plc

 ISIN GB00BY2Z0H74
b)
Nature of the transaction
Purchase of shares in market
c)
Price(s) and volume(s)
Name
Price(s)
Volume(s)
Robert Lyne
GBP 1.23 per share
81,051
Sharon Barber-Lui
GBP 1.24 per share
65,250
John LaMattina
GBP 1.25 per share
59,100
Michele Holcomb
GBP 1.25 per share
29,239
d)
Aggregated information
-
Aggregated volume
-
Price
Price
Aggregate Volume
GBP 1.24 per share
234,640
e)
Date of the transaction
22-23 September 2025
f)
Place of the transaction
London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHPKNBNCBKDACB